Join us for an engaging seminar introducing adoptive cellular immunotherapy, led by CONCEPT’s Principal Scientist, Dr. Brian Philip on the 15th of May at 2pm.
Dr. Philip will also host a session on CONCEPT during NIBRT’s prestigious research conference, “Medicines of the Future,” on the 24th of May, featuring Dr. Larry Bacon, Consultant Haematologist and Clinical Lead for the National Adult CAR-T Centre at St James’s Hospital. Click here for more information on the conference.
Webinar details:
Adoptive cellular immunotherapy (ACT) represents an emerging and evolving therapeutic strategy for malignant and infectious disease. Arising from advances in immunology, transplant medicine, oncology, synthetic biology and gene therapy, ACT has emerged as a disruptive and promising solution for relapsed and refractory disease. Currently six chimeric antigen receptor (CAR) T cell therapies have been approved by the FDA with many more in development. However, despite clear evidence of potential against liquid malignancy, success against solid indications remains largely outstanding whilst risk from therapeutic toxicities highlight opportunity for improvement. An introduction to cellular immunotherapy will consider how current research follows from landmark milestones in the field.